Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035598
Filing Date
2024-08-07
Accepted
2024-08-07 16:05:47
Documents
76
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nexi-20240630.htm   iXBRL 10-Q 840848
2 EX-31.1 nexi-20240630xexx311.htm EX-31.1 10134
3 EX-31.2 nexi-20240630xexx312.htm EX-31.2 10358
4 EX-32.1 nexi-20240630xexx321.htm EX-32.1 3992
5 EX-32.2 nexi-20240630xexx322.htm EX-32.2 4209
  Complete submission text file 0001628280-24-035598.txt   5467045

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nexi-20240630.xsd EX-101.SCH 45479
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nexi-20240630_cal.xml EX-101.CAL 44768
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nexi-20240630_def.xml EX-101.DEF 193238
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nexi-20240630_lab.xml EX-101.LAB 599699
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nexi-20240630_pre.xml EX-101.PRE 410298
79 EXTRACTED XBRL INSTANCE DOCUMENT nexi-20240630_htm.xml XML 598832
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 241183595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)